About Interpharma Group
Interpharma Group is a company. It operates as a B2B and B2C. Interpharma Group offers products and services including Pharmaceuticals and Animal Health Products.
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Inter Pharma Public Company Limited
-
Annual Revenue
$55.33 M (USD)6.52as on Dec 31, 2024
-
Net Profit
$1.09 M (USD)-26.6as on Dec 31, 2024
-
EBITDA
$5.01 M (USD)-9.44as on Dec 31, 2024
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Interpharma Group
Interpharma Group is a publicly listed company on the SET with ticker symbol IP in Thailand, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Interpharma Group
Interpharma Group offers a comprehensive portfolio of products and services, including Pharmaceuticals and Animal Health Products.
Medicines and supplements are developed and distributed for human health using advanced technology.
Vaccines and nutritional products are provided for animal care to ensure safety and efficacy.
Funding Insights of Interpharma Group
Investments & Acquisitions by Interpharma Group
Financial Statements - Interpharma Group
Interpharma Group Comparisons
Competitors of Interpharma Group
Frequently Asked Questions about Interpharma Group
Annual revenue of Interpharma Group is $55.33M as on Dec 31, 2024.
Interpharma Group is known for its dedication to providing efficient health care solutions for humans and animals. Advanced technologies and innovative manufacturing processes are employed to produce high-quality pharmaceuticals, nutraceuticals, and veterinary products that emphasize safety and value. Operations are conducted across multiple sites in Thailand, where products like medicines, supplements, and vaccines are developed to promote longevity and disease prevention. The companys efforts are aimed at enhancing well-being through reliable and effective offerings, with a focus on both human and animal health sectors.
Interpharma Group offers Pharmaceuticals and Animal Health Products.
Yes, Interpharma Group is publicly traded on SET under the ticker symbol IP.
The ticker symbol of Interpharma Group is IP on SET.